Pharma Five is a registered firm based in India. We specialize in Named Patient Imports, Imported cancer drugs, Imported medicines in india.
Contact Us Pharma Five Door No. 74, Old No. 26, Fagun Mansion, 3rd Floor, Ethiraj Salai, Egmore, Chennai - 600008 +916374297988 info@pharmafive.org
Medicine name : Pirtobrutinib
Generic name : Jaypirca
Manufactured By : Eli Lilly
Indications : Relapsed/Refractory CLL/SLL
Medicine Description : A targeted oral therapy for relapsed or refractory chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL), Pirtobrutinib (Jaypirca) is a highly selective, non-covalent Bruton tyrosine kinase (BTK) inhibitor designed to overcome resistance to prior BTK inhibitors. It is used in patients whose disease has progressed after previous treatments. Taken orally, it offers sustained BTK inhibition and improved disease control. Common side effects include fatigue, diarrhea, bruising, anemia, and infections. Regular monitoring of blood counts and infection risk is recommended during treatment.